Croucher, P., Hijzen, A., Shipman, C., Perry, M., Lippitt, J., Green, J., . . . Vanderkerken, K. (2001). Zoledronic acid inhibits the development of osteolytic bone disease and increases disease free survival in a murine model of multiple myeloma.
शिकागो शैली (17वां संस्करण) प्रशस्ति पत्रCroucher, P., A. Hijzen, C. Shipman, M. Perry, J. Lippitt, J. Green, B. Van Camp, और K. Vanderkerken. Zoledronic Acid Inhibits the Development of Osteolytic Bone Disease and Increases Disease Free Survival in a Murine Model of Multiple Myeloma. 2001.
एमएलए (9वां संस्करण) प्रशस्ति पत्रCroucher, P., et al. Zoledronic Acid Inhibits the Development of Osteolytic Bone Disease and Increases Disease Free Survival in a Murine Model of Multiple Myeloma. 2001.
चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.